Artemis Med Service Ltd

ARTEMISMED NSE Healthcare Hospital
₹344.90
-1.05%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.28.
  • Comfortable interest cover: operating profit covers interest about 6.7 times.
  • Return on equity is moderate at 12%.
  • Return on capital employed is moderate at 14.6%.
  • Net profit margin is 9.6%.
  • Profit has compounded about 77% a year over five years.
  • Sales have compounded about 22% a year over five years.
  • Pays a dividend (yield about 0.13%).
  • Has paid a dividend in 4 of the last 5 years.
  • Promoters hold a majority stake (58.39%).

!Watch-points

  • Recent profit growth (33%) is slower than the five-year pace (77%).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
4.38

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreStrong
7 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 5,460 Cr
Current Price₹ 344.90
High / Low₹ 362.00 / 203.35
Stock P/E150.61136
Book Value₹ 59.00
Dividend Yield0%
ROCE14.60%
ROE12.00%
Face Value₹ 1.00
Debt to Equity0.28
PEG Ratio1.15
EV / EBITDA24.25
Industry PE51.30
P/B Ratio5.8413076
EPS₹ 6.55
Debt₹ 262 Cr
PAT Margin9.62%
Cash PAT₹ 152 Cr
ICR6.71
Promoter Holding58.39%
FII Holding12.28%
DII Holding2.40%
Public Holding20.76%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years
5 Years 22.00%
3 Years 14.00%
TTM 15.00%
Compounded Profit Growth
10 Years
5 Years 77.00%
3 Years 41.00%
TTM 33.00%
Stock Price CAGR
10 Years
5 Years 56.00%
3 Years 37.00%
1 Year 44.00%
Return on Equity
10 Years
5 Years 11.00%
3 Years 12.00%
Last Year 12.00%
Educational data only. Not a recommendation to buy, sell or hold any security.